Key Developments: Conmed Corp (CNMD.O)
32.03USD
18 Jun 2013
$0.04 (+0.12%)
$31.99
$31.99
$32.10
$31.67
110,007
131,956
$34.86
$24.78
Latest Key Developments (Source: Significant Developments)
Conmed Corp Announces Quarterly Cash Dividend
Conmed Corp announced that Board of Directors has declared a quarterly cash dividend of $0.15 per share, payable on July 8, 2013 to all shareholders of record as of June 17, 2013. Full Article
Conmed Corp Reiterates FY 2013 EPS Guidance; Lowers FY 2013 Revenue Guidance; Issues Q2 2013 Guidance In Line With Analysts' Estimates
Conmed Corp reiterated its fiscal 2013 adjusted earnings per share guidance (EPS) of $1.80-$1.90 which contemplates the effects of the medical device tax and less favorable FX exchange rates. While the Company believe the overall economic environment may improve toward the latter half of 2013, the Company consider it prudent to reduce the estimated fiscal 2013 sales forecast by $15 million to $770-$780 million. For the second quarter of 2013, the Company anticipate sales to approximate $191-$196 million and adjusted earnings per share (EPS) are forecasted to be $0.41-$0.46. The adjusted estimates for the second quarter and full year 2013 exclude unusual matters, such as patent litigation and manufacturing restructuring costs expected to be incurred in 2013 due to the relocation of manufacturing activities from the Westborough, Massachusetts and Tampere, Finland sites to the Company's other facilities. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $1.86 and revenue of $790 million for fiscal 2013; and revenue of $195 million and EPS of $0.45 the second quarter of 2013. Full Article
Conmed Corp Announces Quarterly Cash Dividend
Conmed Corp announced that its Board of Directors has declared a quarterly cash dividend of $0.15 per share, payable on April 5, 2013 to all shareholders of record as of March 15, 2013. Full Article
Conmed Corp Declares Quarterly Cash Dividend
Conmed Corp announced that the Board of Directors declared a quarterly cash dividend of $0.15 pershare, which was paid on January 7, 2013. Full Article
Conmed Corp Reaffirms FY 2013 EPS Guidance; Updates FY 2013 Revenue Guidance To A Range Below Analysts' Estimates
Conmed Corp announced that for fiscal 2013, it expects earnings per share in the range of $1.80-$1.90 on estimated sales of $785-$795 million. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $1.85 on revenue of $796 million for fiscal 2013. Full Article
Conmed Corp Issues FY 2013 Guidance In Line With Analysts' Estimates-Conference Call
Conmed Corp announced that for fiscal 2013, it expects revenue to grow close to $800 million and earnings per share (EPS) in the range of $1.80-$1.90. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $796 million and EPS of $1.85 for fiscal 2013. Full Article
Conmed Corp Announces Quarterly Cash Dividend
Conmed Corp announced that Board of Directors has declared a quarterly cash dividend of $0.15 per share, payable on January 7, 2013 to all shareholders of record as of December 17, 2012. Full Article
Conmed Corp Issues Q4 2012 Guidance In Line With Analysts' Estimates; Lowers High End Of Prior FY 2012 Revenue Guidance; Narrows FY 2012 EPS Guidance To A Range In Line With Analysts' Estimates
Conmed Corp announced that for the fourth quarter of 2012, it expects sales and earnings consistent with previous guidance. It anticipates fourth quarter 2012 sales to approximate $199-$204 million and adjusted earnings per share (EPS) to be in the range of $0.48-$0.52. Based on this outlook for the fourth quarter, the Company is narrowing guidance for fiscal 2012 although it remains within the previously provided wider ranges and expects fiscal 2012 sales of $765-$770 million and adjusted diluted EPS of $1.76 - $1.80. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $199 million and EPS of $0.51 for the fourth quarter of 2012; revenue of $766 million and EPS of $1.76 for fiscal 2012. Full Article
Conmed Corp Reaffirms FY 2012 Guidance-Conference Call
Conmed Corp announced that it expects top line of $765 million to $775 million and earnings per share on an adjusted basis of $1.75 to $1.85 for fiscal 2012. That would be a double-digit increase over the $1.50 of adjusted earnings per share that had in 2011. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $187 million and EPS of $0.40 for the third quarter of 2012; revenue of $768 million and EPS of $1.76 for fiscal 2012. Full Article
Conmed Corp Announces Quarterly Cash Dividend
Conmed Corp announced that its Board of Directors has declared a quarterly cash dividend of $0.15 per share, payable on October 5, 2012 to all shareholders of record as of September 14, 2012. The Board expects that future cash dividends will be paid on a quarterly basis such that the total annual dividend rate based on the quarterly cash dividend will equal $0.60 per share, which is equivalent to a dividend yield of approximately 2.2 percent based on the closing price of CONMED's stock as of August 28, 2012. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
